FABIA BRISARD PIERROT: Open Payments
NPI 1336495472 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $58 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $112 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| Caris MPI, Inc. | 2 | $102 |
| Lundbeck LLC | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: LYNPARZA, JEMPERLI, MI CANCER SEEK, VYEPTI, Enhertu, ULTOMIRIS, ENTYVIO, ELAHERE.
Industry payments across NY — which companies pay providers there.
